Stockreport

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com
PDF Third quarter performance driven by strong portfolio royalty revenue growth2024 full year revenue guidance increased to $160 million - $165 million (previously $140 mill [Read more]